Sfoglia per Autore
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study
2018-01-01 Lanzolla, Giulia; Sabini, E.; Profilo, M. A.; Mazzi, B.; Sframeli, A.; Rocchi, R.; Menconi, F.; Leo, M.; Nardi, M.; Vitti, P.; Marcocci, C.; Marinò, M.
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy
2018-01-01 Marinò, M.; Rotondo Dottore, G.; Ionni, I.; Lanzolla, G.; Sabini, E.; Ricci, D.; Sframeli, A.; Mazzi, B.; Menconi, F.; Latrofa, F.; Vitti, P.; Marcocci, C.; Chiovato, L.
Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis
2019-01-01 Marino, M.; Ionni, I.; Lanzolla, G.; Sframeli, A.; Latrofa, F.; Rocchi, R.; Marcocci, C.
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases
2019-01-01 Lupi, Isabella; Brancatella, Alessandro; Cosottini, Mirco; Viola, Nicola; Lanzolla, Giulia; Sgrò, Daniele; Dalmazi, Giulia Di; Latrofa, Francesco; Caturegli, Patrizio; Marcocci, Claudio
Immune Checkpoint Blockade Anti-PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome
2019-01-01 Lanzolla, Giulia; Coppelli, Alberto; Cosottini, Mirco; Del Prato, Stefano; Marcocci, Claudio; Lupi, Isabella
Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules
2020-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
2020-01-01 Lanzolla, Giulia; Vannucchi, Guia; Ionni, Ilaria; Campi, Irene; Sileo, Federica; Lazzaroni, Elisa; Marinò, Michele
Antioxidant Therapy in Graves’ Orbitopathy
2020-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy
2020-01-01 Nicoli, F.; Lanzolla, G.; Mantuano, M.; Ionni, I.; Mazzi, B.; Leo, M.; Sframeli, A.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M.
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study
2020-01-01 Lanzolla, G.; Ricci, D.; Nicoli, F.; Sabini, E.; Sframeli, A.; Brancatella, A.; Mantuano, M.; Dottore, G. R.; Bucci, I.; Figus, M.; Nardi, M.; Latrofa, F.; Marcocci, C.; Marino, M.
Oxidative Stress in Graves Disease and Graves Orbitopathy
2020-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis
2020-01-01 Rotondo Dottore, Giovanna; Leo, Marenza; Ricciardi, Roberta; Maestri, Michelangelo; Bucci, Ilaria; Lucchi, Marco; Melfi, Franca; Guida, Melania; De Rosa, Anna; Petrucci, Loredana; Ionni, Ilaria; Lanzolla, Giulia; Nicolì, Francesca; Mantuano, Michele; Ricci, Debora; Latrofa, Francesco; Mariotti, Stefano; Marcocci, Claudio; Marinò, Michele
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study
2021-01-01 Lanzolla, G.; Menconi, F.; Nicoli, F.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M.
Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study
2021-01-01 Lanzolla, Giulia; Menconi, Francesca; Nicolì, Francesca; Posarelli, Chiara; Maglionico, Maria Novella; Figus, Michele; Nardi, Marco; Marcocci, Claudio; Marinò, Michele
Genetic profiling of orbital fibroblasts from patients with Graves' orbitopathy
2021-01-01 Dottore, Giovanna Rotondo; Bucci, Ilaria; Lanzolla, Giulia; Dallan, Iacopo; Sframeli, Angela; Torregrossa, Liborio; Casini, Giamberto; Basolo, Fulvio; Figus, Michele; Nardi, Marco; Marcocci, Claudio; Marinò, Michele
Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
2021-01-01 Lanzolla, G.; Marino, M.; Marcocci, C.
Graves’ disease and Graves’ orbitopathy following COVID-19
2021-01-01 Lanzolla, G.; Marcocci, C.; Marino, M.
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial
2021-01-01 Lanzolla, Giulia; Sabini, Elena; Leo, Marenza; Menconi, Francesca; Rocchi, Roberto; Sframeli, Angela; Piaggi, Paolo; Nardi, Marco; Marcocci, Claudio; Marinò, Michele
Statins: A New Hope on the Horizon of Graves Orbitopathy?
2021-01-01 Marino, M.; Lanzolla, G.; Marcocci, C.
Sirolimus as a second-line treatment for Graves' orbitopathy
2022-01-01 Lanzolla, G; Maglionico, M N; Comi, S; Menconi, F; Piaggi, P; Posarelli, C; Figus, M; Marcocci, C; Marino', Michele
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study | 1-gen-2018 | Lanzolla, Giulia; Sabini, E.; Profilo, M. A.; Mazzi, B.; Sframeli, A.; Rocchi, R.; Menconi, F.; Leo, M.; Nardi, M.; Vitti, P.; Marcocci, C.; Marinò, M. | |
| Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy | 1-gen-2018 | Marinò, M.; Rotondo Dottore, G.; Ionni, I.; Lanzolla, G.; Sabini, E.; Ricci, D.; Sframeli, A.; Mazzi, B.; Menconi, F.; Latrofa, F.; Vitti, P.; Marcocci, C.; Chiovato, L. | |
| Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis | 1-gen-2019 | Marino, M.; Ionni, I.; Lanzolla, G.; Sframeli, A.; Latrofa, F.; Rocchi, R.; Marcocci, C. | |
| Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases | 1-gen-2019 | Lupi, Isabella; Brancatella, Alessandro; Cosottini, Mirco; Viola, Nicola; Lanzolla, Giulia; Sgrò, Daniele; Dalmazi, Giulia Di; Latrofa, Francesco; Caturegli, Patrizio; Marcocci, Claudio | |
| Immune Checkpoint Blockade Anti-PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome | 1-gen-2019 | Lanzolla, Giulia; Coppelli, Alberto; Cosottini, Mirco; Del Prato, Stefano; Marcocci, Claudio; Lupi, Isabella | |
| Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules | 1-gen-2020 | Lanzolla, G.; Marcocci, C.; Marino, M. | |
| Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy | 1-gen-2020 | Lanzolla, Giulia; Vannucchi, Guia; Ionni, Ilaria; Campi, Irene; Sileo, Federica; Lazzaroni, Elisa; Marinò, Michele | |
| Antioxidant Therapy in Graves’ Orbitopathy | 1-gen-2020 | Lanzolla, G.; Marcocci, C.; Marino, M. | |
| Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy | 1-gen-2020 | Nicoli, F.; Lanzolla, G.; Mantuano, M.; Ionni, I.; Mazzi, B.; Leo, M.; Sframeli, A.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M. | |
| Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study | 1-gen-2020 | Lanzolla, G.; Ricci, D.; Nicoli, F.; Sabini, E.; Sframeli, A.; Brancatella, A.; Mantuano, M.; Dottore, G. R.; Bucci, I.; Figus, M.; Nardi, M.; Latrofa, F.; Marcocci, C.; Marino, M. | |
| Oxidative Stress in Graves Disease and Graves Orbitopathy | 1-gen-2020 | Lanzolla, G.; Marcocci, C.; Marino, M. | |
| Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis | 1-gen-2020 | Rotondo Dottore, Giovanna; Leo, Marenza; Ricciardi, Roberta; Maestri, Michelangelo; Bucci, Ilaria; Lucchi, Marco; Melfi, Franca; Guida, Melania; De Rosa, Anna; Petrucci, Loredana; Ionni, Ilaria; Lanzolla, Giulia; Nicolì, Francesca; Mantuano, Michele; Ricci, Debora; Latrofa, Francesco; Mariotti, Stefano; Marcocci, Claudio; Marinò, Michele | |
| Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study | 1-gen-2021 | Lanzolla, G.; Menconi, F.; Nicoli, F.; Posarelli, C.; Maglionico, M. N.; Figus, M.; Nardi, M.; Marcocci, C.; Marino, M. | |
| Beneficial effect of low-dose radioiodine ablation for Graves' orbitopathy: results of a retrospective study | 1-gen-2021 | Lanzolla, Giulia; Menconi, Francesca; Nicolì, Francesca; Posarelli, Chiara; Maglionico, Maria Novella; Figus, Michele; Nardi, Marco; Marcocci, Claudio; Marinò, Michele | |
| Genetic profiling of orbital fibroblasts from patients with Graves' orbitopathy | 1-gen-2021 | Dottore, Giovanna Rotondo; Bucci, Ilaria; Lanzolla, Giulia; Dallan, Iacopo; Sframeli, Angela; Torregrossa, Liborio; Casini, Giamberto; Basolo, Fulvio; Figus, Michele; Nardi, Marco; Marcocci, Claudio; Marinò, Michele | |
| Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease | 1-gen-2021 | Lanzolla, G.; Marino, M.; Marcocci, C. | |
| Graves’ disease and Graves’ orbitopathy following COVID-19 | 1-gen-2021 | Lanzolla, G.; Marcocci, C.; Marino, M. | |
| Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial | 1-gen-2021 | Lanzolla, Giulia; Sabini, Elena; Leo, Marenza; Menconi, Francesca; Rocchi, Roberto; Sframeli, Angela; Piaggi, Paolo; Nardi, Marco; Marcocci, Claudio; Marinò, Michele | |
| Statins: A New Hope on the Horizon of Graves Orbitopathy? | 1-gen-2021 | Marino, M.; Lanzolla, G.; Marcocci, C. | |
| Sirolimus as a second-line treatment for Graves' orbitopathy | 1-gen-2022 | Lanzolla, G; Maglionico, M N; Comi, S; Menconi, F; Piaggi, P; Posarelli, C; Figus, M; Marcocci, C; Marino', Michele |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile